Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,626–2,650 of 27,380 studies, newest first · page 106 of 1096.

November 2025 25

  1. 2025-11-20

    EARLY STAGES OF ALZHEIMERS DETECTION

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The model is trained to recognize subtle patterns in the brain—such as structural shrinkage, texture changes, and abnormalities—associated with Alzheimer’s progression. +2 more findings

  2. 2025-11-20

    EARLY STAGES OF ALZHEIMERS DETECTION

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The model is trained to recognize subtle patterns in the brain—such as structural shrinkage, texture changes, and abnormalities—associated with Alzheimer’s progression. +2 more findings

  3. 2025-11-20

    EARLY STAGES OF ALZHEIMERS DETECTION

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The model is trained to recognize subtle patterns in the brain—such as structural shrinkage, texture changes, and abnormalities—associated with Alzheimer’s progression. +2 more findings

  4. 2025-11-19

    Polygenic risk score and cluster-based analysis suggests links between type 2 diabetes and vascular dementia in the KARE study

    ✓ Peer-reviewed Genetics Nature communications

    Key finding: We find that a higher overall polygenic risk score for type 2 diabetes is significantly associated with an increased risk of vascular dementia, but not Alzheimer's disease. +2 more findings

  5. 2025-11-19

    Genetic drivers of progression in Alzheimer's disease are distinct from disease risk

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv : the preprint server for health sciences

    Key finding: Established AD risk factors, including APOE ε4 dosage and polygenic risk scores, were not associated with disease progression amyloid positive individuals who are actively declining. +4 more findings

    Scored 57 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2025-11-19

    The spectrum of Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed Tau biomarkers medRxiv : the preprint server for health sciences

    Key finding: Analyses revealed that no individual volumetric brain changes, nor their combination, can predict AD. +1 more finding

    Scored 33 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2025-11-19

    Needs of key stakeholders to make advance care plans and advance directives for people with dementia: a scoping review

    ✓ Peer-reviewed End-of-life care Repository for Publications and Research Data (ETH Zurich)

    Key finding: Dementia-specific ACP/AD require a relational, flexible and ethically grounded approach that evolves with the individual’s condition. +4 more findings

  8. 2025-11-19

    Development and psychometric evaluation of a learning needs assessment tool for healthcare professionals in palliative dementia care: A cross-sectional study

    ✓ Peer-reviewed End-of-life care International Journal of Nursing Studies Advances

    Key finding: The 29-item needs assessment showed strong internal consistency, with a mean Cronbach’s alpha of .89 and McDonald’s omega of .90. +1 more finding

  9. 2025-11-19
  10. 2025-11-19

    The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation

    ✓ Peer-reviewed Inflammation and the immune system Brain Sciences

    Key finding: Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer's disease (AD). +4 more findings

  11. 2025-11-19

    Cognitive Functioning of Older Women with Diverse Physical Fitness and Independence – Limitations of Dementia Screening in Primary Healthcare

    ✓ Peer-reviewed Cognitive tests and assessment Medical Studies

    Key finding: Wyniki i wnioski Wykazano różnice między grupami A i B w zakresie wszystkich zastosowanych testów przesiewowych (p<0,001). +4 more findings

  12. 2025-11-19

    Delineation of the cognitive and neuropsychiatric features of Pisa syndrome in dementia with Lewy bodies

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in Aging Neuroscience

    Key finding: Our study reveals that PS in DLB is associated with specific deficits in attention and visuospatial/executive function, alongside more severe neuropsychiatric symptoms. +4 more findings

  13. 2025-11-19

    Dysfunctional default mode and visual networks underlie cognitive deficits in dementia with Lewy bodies: a resting-state fMRI study

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in Aging Neuroscience

    Key finding: DLB is characterized by DMN and visual network dysfunction, disrupted local neural activity, and impaired global network integration. +2 more findings

  14. 2025-11-19
  15. 2025-11-19

    Physical Activity Over the Adult Life Course and Risk of Dementia in the Framingham Heart Study

    ✓ Peer-reviewed How common it is JAMA Network Open

    Key finding: This study included 1526 early adult-life (mean [SD] age, 36.7 [4.7] years; 821 [53.8%] female), 1943 midlife (mean [SD] age, 54.0 [5.8] years; 1010 [52.0%] female), and 885 late-life (mean [SD] age, 71.0 [4.5] years; 473 [53.4%] female) participants. +4 more findings

  16. 2025-11-19

    β-Amyloid PET Signal Reduction in Prior ARIA-E Regions after Antiamyloid Therapy for Alzheimer Disease

    ✓ Peer-reviewed Biomarkers American Journal of Neuroradiology

    Key finding: In 4 of 5 patients treated with lecanemab or donanemab and who had moderate or severe ARIA-E, Aβ PET signal decreased significantly more in regions that had been involved with ARIA-E. +2 more findings

  17. 2025-11-19

    Community Socioeconomic Disadvantage Relates to White Matter Hyperintensity Burden in Mid-to-Late Life Adults

    ✓ Peer-reviewed Risk factors Psychosomatic Medicine

    Key finding: Linear regression models showed that higher community deprivation on the ADI was associated with greater WMH volume, independently of age, sex, years of education, smoking, and time between study visits (beta=0.11, p =.028). +3 more findings

  18. 2025-11-18

    The Integration of Lifestyle Modification Advice and Diet and Physical Exercise Interventions: Cornerstones in the Management of Obesity with Incretin Mimetics

    ✓ Peer-reviewed Prevention and risk Obesity Facts

    Key finding: The introduction of incretin mimetics (IMs), including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as liraglutide and semaglutide, as well as dual GLP-1/glucose-dependent insulinotropic polypeptide receptor co-agonists (GLP-1/GIP RAs) like tirzepatide, has revolutionized obesity treatment. +1 more finding

  19. 2025-11-18

    Cognitive Age Delta as a Marker of Healthy and Pathological Cognitive Aging: The Role of Lifestyle, Cognitive Reserve, and Vascular Risk

    ✓ Peer-reviewed Genetics Journal of Clinical Medicine

    Key finding: CAD did not differ across biomarker groups (Kruskal–Wallis H(2) = 0.17, p = 0.91). +4 more findings

  20. 2025-11-17

    Unfolded proteins and aggregates: The role of proteostasis in pseudoexfoliation pathology

    ✓ Peer-reviewed Disease mechanisms Molecular vision

    Key finding: Evidence indicates that chronic proteotoxic stress, arising from aging, oxidative damage, and environmental influences, disrupts the proteostasis network (PN). +4 more findings

  21. 2025-11-17
  22. 2025-11-17

    Real-world application of lecanemab in early-stage alzheimer's disease: a single-center prospective cohort analysis

    ✓ Peer-reviewed Treatments Alzheimer's research & therapy

    Key finding: The mean age was 66 years (65.53 ± 9.31), and 51 (67.1%) participants being female. +4 more findings

  23. 2025-11-17

    Spatial Multi-Omics Workflow and Analytical Guidelines for Alzheimer's Neuropathology

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv : the preprint server for biology

    Key finding: Here, we present an end-to-end pipeline for the GeoMx Digital Spatial Profiler that simultaneously generates whole-transcriptome and 637-protein measurements from user-defined regions within the same tissue sections. +4 more findings

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  24. 2025-11-17

    Developing educational materials to aid in Alzheimer's blood biomarker disclosure

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (New York, N. Y.)

    Key finding: Participants rated the materials highly regarding value and comprehension. +4 more findings

  25. 2025-11-17

    Intercellular signaling and synaptic deconstruction uncovered by single-cell and spatial transcriptomics in an AD tauopathy model

    ✓ Peer-reviewed Disease mechanisms Communications Biology

    Key finding: Our findings reveal how tau hyperphosphorylation and aging alter ligand-receptor communication, transcription factor regulatory networks, and specific cellular networks. +2 more findings

Browse the library by subject, with the full score breakdown →